SEC Form 4 · accession 0001104659-15-080790
Axsome Therapeutics, Inc. · AXSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Jeffs
Director
Period of report
Nov 19, 2015
Accepted (ET)
Nov 23, 2015 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001579428
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $9.00 | Nov 19, 2015 | A | 9,127 | A | — | Nov 18, 2025 | Common Stock | 9,127 | 9,127 | D |
Explanation of responses
- F1The option vests in full on the one-year anniversary of the date of grant, November 19, 2016.